Jan 5, 2022

Management of Male Breast Cancer: The Journey so Far and Future Directions
By Quratulain (Anna) Sabih et al. World Journal of Oncology, Vol. 12, No. 6, Dec 2021

Male breast cancer is now shown to be a unique entity and should be considered as a distinct disease. Given the relatively smaller number of cases, randomized controlled trials for treatment are extremely limited and majority of practices are derived from female breast cancer studies.  Read More.... 
 

Jan 5, 2022
Effects of Influenza Vaccination on the Response to BNT162b2 Messenger RNA COVID-19 Vaccine in Healthcare Workers 
By Marilena Greco et al. Journal of Clinical Medicine Research, Vol. 13, No. 12, Dec 2021

Vaccine-induced immunity is at present the main strategy to stop the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent evidences suggested a protective effect of influenza vaccination against coronavirus disease 2019 (COVID-19) severity, while impact on the immune response to BNT162b2 messenger RNA (mRNA) vaccine is under investigation.  Read More.... 

Dec 21, 2021

Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study 
By Adam Jona et al. Journal of Hematology, Vol. 10, No. 6, Dec 2021

Standard bleomycin-containing first-line therapy and/or irradiation may cause pulmonary toxicity in Hodgkin lymphoma (HL) patients. Our aim was to prospectively assess effects of chest irradiation, bleomycin administration, and other factors on lung function in the treatment of patients with HL. Pulmonary function of newly diagnosed HL patients was assessed via a St. George Respiratory Questionnaire, dynamic inhalation lung scintigraphy, spirometry, and an assessment of the diffusion capacity of the lung for carbon monoxide (DLCO) before, during, and after treatment. Read More.... 
 

Let's Combat COVID-19 Together.
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and healthcare givers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.  For more information, please contact production@elmerpress.com or the individual journal's editor.
View our published articles on COVID-19